Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma

Xue Li; Dengfeng Zhang; Pengfei Guo; Shaowei Ma; Shaolin Gao; Shujun Li; Yadong Yuan

doi:doi:10.18632/aging.205705

← Back

Research Paper Volume 16, Issue 7 pp 6290—6313

Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma

Figure 1. Landscape of 31 ICDGs in LUAD. (A) Circus plots of chromosome distributions of ICDGs. (B) Expression distributions of ICDGs between LUAD and normal tissues. (C) Heatmap shows 31 ICDGs expression profiles among normal and LUAD samples. (D) The CNV mutation frequency of ICDGs. (E) Somatic mutation spectrums of ICDGs. (F) Correlation between 31 ICDGs in TCGA-LUAD. ^*p < 0.05, ^**p < 0.01, ^***p < 0.001.